AlignRx

NEW YORK, August 15, 2024 – Inc. revealed today that AlignRx ranks No. 1411 on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Microsoft, Meta, Chobani, Under Armour, […]

As the pipeline of drugs for diabetes management continues to grow, benefit partners and advisors and the employer groups they serve are positioned to influence significant decisions that will impact healthcare spending. With some groups spending millions for diabetic drugs alone, it’s critical to understand the full spectrum of medications available, including newer players like

Traditional drug pipelines are now increasingly dominated by specialty drugs, many of which carry a six-figure annual per patient cost. This shift poses a significant financial challenge for health plans.

BenefitsPRO, the No.1 provider of news, analysis and trends for benefits professionals, has announced its 2023 Luminaries Awards recognizing excellence in the benefits industry. Kevin Kobielski, president & CEO of AlignRx was recognized in the Leadership category.  One of only nine individuals awarded in this category this year, Kevin is featured in the October 2023 issue

Inc. revealed today that AlignRx Consulting ranks No. 898 on the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment — its independent, entrepreneurial businesses.  AlignRx partners with benefit consultants, employer groups, TPAs